Formic Acid

Formic Acid

SCHEMBL3582950

NCCCC(N)CNC1CCCCC1.O=CO

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 4/20 0.46
ERAP2 Q6P179 4/20 0.46
KDM4E B2RXH2 2/20 0.43
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CPB2 Q96IY4 2/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
SCN1A P35498 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
ADH1B P00325 1/20 0.32
ADH1C P00326 1/20 0.32
ADH1A P07327 1/20 0.32
ADH4 P08319 1/20 0.32
BCHE P06276 1/20 0.32
METAP1 P53582 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9810147 0.80 KDM4E (0.50) ANPEPERAP2KDM4EHTTSMN1; SMN2
SCHEMBL3585774 0.80 KDM4E (0.50) ANPEPERAP2KDM4EHTTSMN1; SMN2
SCHEMBL3582949 0.76 ANPEP (0.40) ANPEPERAP2KDM4EHTTSMN1; SMN2
SCHEMBL28990566 0.76 ANPEP (0.38) ANPEPERAP2KDM4E
SCHEMBL21192378 0.76 ANPEP (0.38) ANPEPERAP2KDM4E
SCHEMBL2801217 0.73 KDM4E (0.54) ANPEPERAP2KDM4EHTTSMN1; SMN2
SCHEMBL11437981 0.72 KDM4E (0.48) ANPEPERAP2KDM4EHTTSMN1; SMN2
SCHEMBL16506340 0.71 CXCR4 (0.39) ANPEPERAP2KDM4ECPB2
SCHEMBL29100048 0.70 KDM4E (0.50) ANPEPERAP2KDM4EHTTSMN1; SMN2
SCHEMBL28080703 0.68 KDM4E (0.52) ANPEPERAP2KDM4EHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048549-A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 Wurster, Siegfried (FI) 2010-02-25 US disclosed
EP-1885693-A1 PEPTIDOMIMETICS SELECTIVE FOR THE SOMATOSTATIN RECEPTOR SUBTYPES 1 AND/OR 4 Wurster, Siegfried (FI) 2008-02-13 EP disclosed
WO-2006123020-A1 PEPTIDOMIMETICS SELECTIVE FOR THE SOMATOSTATIN RECEPTOR SUBTYPES 1 AND/OR 4 JUVANTIA PHARMA LTD OY (FI) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048549-A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 SSTR1, SSTR4, SSTR3 ANPEP 200/4885ERAP2 1692/4885KDM4E 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.